These functional data support the view that FAM189A2 acts as a negative regulator of metastatic potential in lung cancer cells and are directionally consistent with its association with the favorable early GPRC5A+ malignant program in our single−cell analyses. This evidence concerns the gene ENTREP1 and lung carcinoma.